PRP Therapy for Plantar Fasciitis in Milwaukee, WI

What I’d check before adding prp plantar fasciitis here

CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Census city-proper population is 577,222. If you are adding prp plantar fasciitis, start with that epidemiology and with National Government Services (NGS) (J6) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 23.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 14.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Wisconsin.
• In a city of 500k–1M, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Milwaukee street address.
• Wisconsin is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Uninsured mix and Medicare CTPs in the same building

J6 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Milwaukee is 14.7% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic